Skip to main content
. 2020 Sep 2;12(9):2486. doi: 10.3390/cancers12092486
BBB Blood–brain barrier
CNS Central nervous system
CSF Cerebrospinal fluid
CXCL1 Chemokine (C-X-C motif) ligand 1
ECs Endothelial cells
EGFR Epidermal growth factor receptor
EPHA2 Ephrin type A receptor 2
EVs Extracellular vesicles
GA-MSCs Glioma-associated (GA) mesenchymal stem cells (MSCs)
GBM Glioblastoma multiforme
GDEs GSC-derived exosomes
GSCs Glioma stem-like cells
HB-EGF Heparin-binding EGF-like growth factor
hBMSCs human bone marrow MSCs
HBMVECs human brain microvascular endothelial cells
IL-6 Interleukin-6
IL-8 Interleukin-8
MCP3 Monocyte-chemotactic protein 3
miRNAs microRNAs
MMPs Matrix metalloproteinases
MSCs Mesenchymal stem cells
MVs Microvesicles
MVBs Multivesicular bodies
NSCs Neural stem cells
NRP1 Neuropilin
ncRNAs noncoding RNAs
PD-1 Programmed cell death-1
PD-L1 Programmed death-ligand 1
plxA1 PlexinA1
rGBM Recurrent GBM
Sema Semaphorins
Sema3A Semaphorin3A
Sema3C Semapahorin3C
STAT3 Signal transducer and activator of transcription 3
TAMs Tumor-associated macrophages
TF Tissue factor
TIMP-1 Tissue inhibitor of metalloproteinase-1
TIMP-2 Tissue inhibitor of metalloproteinase-2
TME Tumor microenvironment
VEGF Vascular endothelial growth factor
VEGFR2 Vascular endothelial growth factor receptor 2